Anti-Group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection

Vaccine

Volumn 33, Issue 5, 2015, Pages 621-627

  Le Doare, Kirsty ^a,b   Allen, Lauren ^c   Kampmann, Beate ^a,d   Heath, Paul Trafford ^b   Taylor, Stephen ^c   Hesseling, Anneke C ^e   Gorringe, Andrew ^c   Jones, Christine Elizabeth ^a,b,e  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antibody; Group B Streptococcus; HIV; HIV exposed uninfected infants; Immunity

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3B; GROUP B STREPTOCOCCUS ANTIBODY; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; COMPLEMENT;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PLACENTAL TRANSFER; PRIORITY JOURNAL; SEROTYPE; SOUTH AFRICAN; STREPTOCOCCUS AGALACTIAE; BLOOD; COHORT ANALYSIS; IMMUNOLOGY; MALE; NEWBORN; PASSIVE IMMUNIZATION; PREGNANCY; PREGNANCY COMPLICATION; SOUTH AFRICA;

ANTIBODIES, BACTERIAL; COHORT STUDIES; COMPLEMENT SYSTEM PROTEINS; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOUTH AFRICA; STREPTOCOCCUS AGALACTIAE;

EID: 84921263867     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.025     Document Type: Article

References (36)

1. Joint United Nations Programme on HIV and AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic: 2010 2010.
2. Marinda E., Humphrey J.H., Iliff P.J., Mutasa K., Nathoo K.J., Piwoz E.G., et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007, 26:519-526.
3. McNally L.M., Jeena P.M., Gajee K., Thula S.A., Sturm A.W., Cassol S., et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007, 369:1440-1451.
4. Kuhn L., Kasonde P., Sinkala M., Kankasa C., Semrau K., Scott N., et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?. Clin Infect Dis 2005, 41:1654-1661.
5. Le Doare K., Heath P.T. An overview of global GBS epidemiology. Vaccine 2013, 31:D7-D12.
6. Gray K.J., Kafulafula G., Matemba M., Kamdolozi M., Membe G., French N. Group B streptococcus and HIV infection in pregnant women. Malawi, 2008-2010. Emerg Infect Dis 2011, 17:1932-1935.
7. Epalza C., Goetghebuer T., Hainaut M., Prayez F., Barlow P., Dediste A., et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010, 126:e631-e638.
8. Baker C.J., Carey V.J., Rench M.A., Edwards M.S., Hillier S.L., Kasper D.L., et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2014, 209:781-788.
9. Kasper D.L., Paoletti L.C., Wessels M.R., Guttormsen H.K., Carey V.J., Jennings H.J., et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996, 98:2308-2314.
10. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976, 294:753-756.
11. Suara R.O., Adegbola R.A., Mulholland E.K., Greenwood B.M., Baker C.J. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns. J Natl Med Assoc 1998, 90:109-114.
12. Lin F.Y., Weisman L.E., Azimi P.H., Philips J.B., Clark P., Regan J., et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 2004, 190:928-934.
13. Hall M.A., Edwards M.S., Baker C.J. Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci. Infect Immun 1992, 60:5030-5035.
14. Edwards M.S., Lane H.J., Hillier S.L., Rench M.A., Baker C.J. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine 2012, 30:4123-4126.
15. Baker C.J., Paoletti L.C., Rench M.A., Guttormsen H.K., Edwards M.S., Kasper D.L. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis 2004, 189:1103-1112.
16. Caceres V.M., Strebel P.M., Sutter R.W. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 2000, 31:110-119.
17. Cumberland P., Shulman C.E., Maple P.A., Bulmer J.N., Dorman E.K., Kawuondo K., et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007, 196:550-557.
18. Healy C.M., Munoz F.M., Rench M.A., Halasa N.B., Edwards K.M., Baker C.J. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004, 190:335-340.
19. Jones C.E., Naidoo S., De Beer C., Esser M., Kampmann B., Hesseling A.C. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. J Am Med Assoc 2011, 305:576-584.
20. Jones C.E., Hesseling A.C., Tena-Coki N.G., Scriba T.J., Chegou N.N., Kidd M., et al. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS 2014, [in press].
21. Barron P., Pillay Y., Doherty T., Sherman G., Jackson D., Bhardwaj S., et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ 2013, 91:70-74.
22. Brookes C., Kuisma E., Alexander F., Allen L., Tipton T., Ram S., et al. Development of a large scale human complement source for use in bacterial immunoassays. J Immunol Methods 2013, 391:39-49.
23. Frigati L., van der Merwe H., Theron G., Rabie H., Harvey J., Cotton M.F. A retrospective review of group B streptococcal infection - 2010-2011 2013, World Society for Paediatric Infectious Diseases, Cape Town, South Africa, OP1, abstract 1.
24. Cutland C.L., Maribe A., Groome M.J., Velaphi S.C., Khoosal M., Wadula J., et al. Invasive group B streptococcus sepsis in young South African infants in the rea of high maternal HIV infection rates (2004-2008) 2013, World Society for Paediatric Infectious Diseases, Cape Town, South Africa, OP2, abstract 2.
25. Gupta A., Mathad J.S., Yang W.T., Singh H.K., Gupte N., Mave V., et al. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs. Vaccine 2014, 32:1466-1472.
26. Madzivhandila M., Adrian P.V., Cutland C.L., Kuwanda L., Madhi S.A., Po P.S.T.T. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol 2013, 62:249-253.
27. Simani O.E., Adrian P.V., Violari A., Kuwanda L., Otwombe K., Nunes M.C., et al. Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS 2013, 27:1583-1591.
28. Seale A.C., Mwaniki M., Newton C.R., Berkley J.A. Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 2009, 9:428-438.
29. Hygino J., Lima P.G., Filho R.G., Silva A.A., Saramago C.S., Andrade R.M., et al. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008, 127:340-347.
30. Clerici M., Saresella M., Colombo F., Fossati S., Sala N., Bricalli D., et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000, 96:3866-3871.
31. Mussi-Pinhata M.M., Freimanis L., Yamamoto A.Y., Korelitz J., Pinto J.A., Cruz M.L., et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007, 119:e694-e704.
32. Koyanagi A., Humphrey J.H., Ntozini R., Nathoo K., Moulton L.H., Iliff P., et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011, 30:45-51.
33. Newell M.L., Coovadia H., Cortina-Borja M., Rollins N., Gaillard P., Dabis F., et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364:1236-1243.
34. Quan V., Cohen C., Madhi S.A. Paediatric invasive group B streptococcal disease in South Africa, 2004 to 2011 2013, World Society for Paediatric Infectious Diseases, Cape Town, South Africa, OP3, abstract 3.
35. Gray K.J., Bennett S.L., French N., Phiri A.J., Graham S.M. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis 2007, 13:223-229.
36. Mayer E., Mendez H., Gesner M., Desai N., Hammerschlag M.R. HIV-exposed uninfected infants are not at risk of developing group B streptococal infection 2013, World Society for Paediatric Infectious Diseases, Cape Town, South Africa, OP4, abstract 4.